IL13RA2 and adrenal cortex carcinoma: By analyzing the National Cancer Institute’s TCGA database, we demonstrated that IL13Rα2 gene expression is related with the survival of patients with ACC where analysis indicated that high IL-13Rα2 expression is associated with negative clinical outcomes as measured by four different metrics.